Hisun Pharmaceutical and Tigermed (03347.HK) signed a strategic cooperation
framework. The pact covers innovative-drug business development (BD) and joint
investment, clinical research, digital clinical services and talent development,
with both parties citing complementary strengths to boost innovative-business
competitiveness and support coordinated development of the Chinese
pharmaceutical industry.